Rare diseases
Investigational molecules
Locations
Back to Belgium48 clinical trials in Mons, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on lung cancer treatments, including studies of combination therapies with BNT327 and investigations into both small cell and non-small cell variants. Additional research covers breast cancer and cervical cancer treatments.
Studies aim to improve survival rates and treatment effectiveness through targeted therapies and immunotherapy combinations.
Comprehensive research into coronary artery disease and post-stroke treatments, evaluating new antiplatelet therapies and innovative stent technologies. Studies focus on reducing cardiovascular events and improving patient outcomes.
Investigations aim to enhance treatment protocols and reduce cardiovascular complications.
Groundbreaking research in multiple sclerosis and psoriatic arthritis treatments, evaluating novel therapeutic approaches including BTK inhibitors and biological treatments.
Focus on improving quality of life and disease management for patients with chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
